Bifidobacterium longum relieves constipation by regulating the intestinal barrier of mice

Linlin Wang,Mao Chai,Jialiang Wang,Qiangqing Yu,Gang Wang,Hao Zhang,Jianxin Zhao,Wei Chen,Qiangqing YU

DOI: https://doi.org/10.1039/d1fo04151g

2022-01-01

Abstract:Constipation is a major health concern worldwide, requiring effective and safe treatment options.

biochemistry & molecular biology,food science & technology

What problem does this paper attempt to address?

Screening of Novel Probiotics with Intestinal Peristalsis-Promoting Potential Based on in Vitro and in Vivo Investigations

Fei Shen,Jiachen Zhuang,Qianqian Wang,Junhui Zhang,Tao Liu,Shenyue Ruan,Juan Du,Hao Zhong,Mingjie Zhao,Fengqin Feng

DOI: https://doi.org/10.1016/j.fbio.2023.102681

IF: 5.318

2023-01-01

Food Bioscience

Abstract:Constipation is a widespread gastrointestinal issue. This work aimed to investigate anti-constipation capacities of 9 novel strains of Lactobacillus and Bifidobacterium using in vitro experiments for initial exploration and then further confirmed through in vivo models including both zebrafish and mice. The in vitro experimental results revealed that L. plantarum T34 and L. paracasei YJ10 could survive under the simulated gastrointestinal tract conditions as standard strain L. rhamnosus (LGG) did. L. paracasei YJ10 and L. casei Lc showed the highest 22 h's aggregation rate. L. rhamnosus W1 showed the highest coaggregation rate with E. coli and with S. aureus. T34 had the largest inhibition zones against S. typhimurium and L. Monocytogenes. The highest adhesion rates with HT-29 cells were L. casei Lc, LGG and W1. Principal component analysis (PCA) and Fuzzy synthetic evaluation (FSE) were performed to evaluate the in vitro probiotic potential of the 9 strains comprehensively. The order of scores on in vitro probiotic property from high to low was as follows: T34, W1, YJ10, Lc, LGG, SLT, SS, Lb, YN4 and LQSQ. The subsequent in vivo experiment of zebrafish further confirmed T34, W1 and YJ10 have better anticonstipation ability compared to other strains. Furthermore, T34 relieve loperamide-induced constipation by promoting gut transit in the mice model. In conclusion, T34 was demonstrated to prevent constipation and may be suggested for use in food and pharmaceutical goods.
Bifidobacterium longum subsp. longum relieves loperamide hydrochloride-induced constipation in mice by enhancing bile acid dissociation

Chenyue Zhang,Linlin Wang,Xiaoming Liu,Gang Wang,Jianxin Zhao,Wei Chen

DOI: https://doi.org/10.1039/d4fo04660a

IF: 6.3173

2024-12-14

Food & Function

Abstract:Bifidobacterium species are known for their efficacy in alleviating constipation. This study aimed to compare the constipation-relieving effects of different Bifidobacterium species ( Bifidobacterium longum subsp. longum , Bifidobacterium bifidum , Bifidobacterium animalis , Bifidobacterium breve , Bifidobacterium longum subsp. infantis , and Bifidobacterium adolescentis ) and to explore the underlying mechanisms from both the bacterial and host perspectives. We evaluated six Bifidobacterium species for their physiological properties, including growth rate, oligosaccharide utilization, osmotic pressure resistance, cell adhesion, and bile acid dissociation capability. Mice with severe constipation induced by loperamide hydrochloride were treated with these bacteria at a density of 10 9 CFU per mL for 17 days. Gastrointestinal indices such as fecal water content, time to first black stool defecation, and small intestine propulsion rate were measured to assess constipation relief. Microbiome and metabolome (bile acid and tryptophan) analyses were conducted to elucidate the differences in constipation relief among the species. Our results demonstrated that Bifidobacterium longum subsp. longum exhibited superior physiological traits, including rapid growth, extensive oligosaccharide utilization, and high bile salt dissociation capacity. Notably, only Bifidobacterium longum subsp. longum significantly ameliorated constipation symptoms in the mouse model. Furthermore, this strain markedly restored bile acid and short-chain fatty acid levels in the intestines of constipated mice and altered the composition of the intestinal microbiota. These findings suggest that the enhanced efficacy of Bifidobacterium longum subsp. longum in relieving constipation is associated with its ability to modulate intestinal physiology and microbiota structure and metabolism.

biochemistry & molecular biology,food science & technology
Bifidobacterium longum S3 alleviates loperamide-induced constipation by modulating intestinal acetic acid and stearic acid levels in mice

Tong Zhang,Huimin Lu,Ting Cheng,Linlin Wang,Gang Wang,Hao Zhang,Wei Chen

DOI: https://doi.org/10.1039/d4fo00695j

IF: 6.3173

2024-05-22

Food & Function

Abstract:Constipation is a major gastrointestinal (GI) symptom worldwide, with diverse causes of formation, and requires effective and safe therapeutic measures. In the present study, we used loperamide hydrochloride to establish a constipation model and assessed the effect of Bifidobacterium on constipation and its possible mechanism of relief. The results showed that B. longum S3 exerted a constipation-relieving effect primarily by improving the gut microbiota, enriching genera including Lactobacillus , Alistipes , and Ruminococcaceae UCG-007 , and decreasing the bacteria Lachnospiraceae NK4B4 group. These changes may thereby increase acetic acid and stearic acid (C18:0) levels, which significantly increase the expression levels of ZO-1 and MUC-2, repair intestinal barrier damage and reduce inflammation (IL-6). Furthermore, it also inhibited oxidative stress levels (SOD and CAT), decreased the expression of water channel proteins (AQP4 and AQP8), significantly elevated the Gas, 5-HT, PGE2, and Ach levels, and reduced nNOS and VIP levels to improve the intestinal luminal transit time and fecal water content. Collectively, these changes resulted in the alleviation of constipation.

biochemistry & molecular biology,food science & technology
Different Bifidobacterium bifidum strains change the intestinal flora composition of mice via different mechanisms to alleviate loperamide-induced constipation

Mao Chai,Linlin Wang,Xinping Li,Jianxin Zhao,Hao Zhang,Gang Wang,Wei Chen

DOI: https://doi.org/10.1039/d1fo00559f

2021-01-01

Abstract:B. bifidum had intraspecies differences in relieving constipation. It can promote intestinal peristalsis by gastrointestinal active peptides. Specially, FXJCJ32M2 may promote the expression of AQP8 and VIPR1 through gut microbiota modulation.

biochemistry & molecular biology,food science & technology
Bifidobacterium bifidum CCFM1163 Alleviated Cathartic Colon by Regulating the Intestinal Barrier and Restoring Enteric Nerves

Nan Tang,Qiangqing Yu,Chunxia Mei,Jialiang Wang,Linlin Wang,Gang Wang,Jianxin Zhao,Wei Chen

DOI: https://doi.org/10.3390/nu15051146

IF: 5.9

2023-02-25

Nutrients

Abstract:Cathartic colon (CC), a type of slow-transit constipation caused by the long-term use of stimulant laxatives, does not have a precise and effective treatment. This study aimed to evaluate the ability of Bifidobacterium bifidum CCFM1163 to relieve CC and to investigate its underlying mechanism. Male C57BL/6J mice were treated with senna extract for 8 weeks, followed by a 2-week treatment with B. bifidum CCFM1163. The results revealed that B. bifidum CCFM1163 effectively alleviated CC symptoms. The possible mechanism of B. bifidum CCFM1163 in relieving CC was analyzed by measuring the intestinal barrier and enteric nervous system (ENS)-related indices and establishing a correlation between each index and gut microbiota. The results indicated that B. bifidum CCFM1163 changed the gut microbiota by significantly increasing the relative abundance of Bifidobacterium, Faecalibaculum, Romboutsia, and Turicibacter as well as the content of short-chain fatty acids, especially propionic acid, in the feces. This increased the expression of tight junction proteins and aquaporin 8, decreased intestinal transit time, increased fecal water content, and relieved CC. In addition, B. bifidum CCFM1163 also increased the relative abundance of Faecalibaculum in feces and the expression of enteric nerve marker proteins to repair the ENS, promote intestinal motility, and relieve constipation.

nutrition & dietetics
Bifidobacterium animalis F1-7 in combination with konjac glucomannan improves constipation in mice via humoral transport

Youyou Lu,Zhuang Yu,Zhe Zhang,Xi Liang,Pimin Gong,Huaxi Yi,Liuqing Yang,Tongjie Liu,Hanping Shi,Lanwei Zhang

DOI: https://doi.org/10.1039/d0fo02227f

2021-01-01

Abstract:Bifidobacterium animalis F1-7 in combination with konjac glucomannan promoted the metabolism of tryptophan and short-chain fatty acids, regulated humoral transport and improved constipation.

biochemistry & molecular biology,food science & technology
Lactobacillus paracasei Relieves Constipation by Acting on the Acetic Acid-5-HT-Intestinal Motility Pathway

Linlin Wang,Shurong Yang,Chunxia Mei,Nan Tang,Jialiang Wang,Qiangqing Yu,Gang Wang,Gaojue Wu,Jianxin Zhao,Wei Chen

DOI: https://doi.org/10.3390/foods12224176

IF: 5.2

2023-11-20

Foods

Abstract:Constipation is a major health concern worldwide and requires effective and safe treatment options. In this study, we selected ten strains of two species of lactobacilli to identify whether they were effective against constipation induced by loperamide administration in BALB/c mice. Monitoring of constipation-related indicators indicated that Lactobacillus paracasei (L. paracasei) mainly acted on the whole intestinal peristalsis to relieve constipation. Furthermore, through the detection of biological, chemical, mechanical, and immune barriers in mice, it was discovered that L. paracasei changed the relative abundance of bacteria related to the levels of acetic acid and 5-hydroxytryptamine (5-HT) (such as by increasing the relative abundance of Odoribacter and Clostridium, and reducing the relative abundance of Mucispirillum, Ruminococcus, Coprobacillus, and Dorea), increased the concentration of acetic acid in the intestine, which stimulated enterochromaffin cells, promoted 5-HT synthesis in the colon, enhanced intestinal motility, and relieved constipation. In conclusion, this study provides a theoretical foundation for the development of personalized products for the treatment of constipation.
A randomised, double-blind, placebo-controlled trial of Bifidobacterium bifidum CCFM16 for manipulation of the gut microbiota and relief from chronic constipation

Luyao Wang,Linlin Wang,Peijun Tian,Botao Wang,Shumao Cui,Jianxin Zhao,Hao Zhang,Long Qian,Qun Wang,Wei Chen,Gang Wang

DOI: https://doi.org/10.1039/d1fo03896f

2022-01-01

Abstract:CCFM16 raises Firmicutes and Clostridia then SCFAs levels to relieve constipation. Several taxa in Clostridiales prevent CCFM16 from properly functioning.

biochemistry & molecular biology,food science & technology
<i>Bifidobacterium longum</i>alleviates irritable bowel syndrome-related visceral hypersensitivity and microbiota dysbiosis via Paneth cell regulation

Chunhua Zhou,Xue Fang,Jiajia Xu,Jun Gao,Ling Zhang,Jiulong Zhao,Yuting Meng,Wei Zhou,Xu Han,Yu Bai,Zhaoshen Li,Duowu Zou

DOI: https://doi.org/10.1080/19490976.2020.1782156

IF: 12.2

2020-01-01

Gut Microbes

Abstract:Although the oral administration ofBifidobacterium longum(B. longum) relieves the signs of irritable bowel syndrome (IBS) in clinical settings, the mechanisms underlying its effects are unclear. In this study, we evaluated the precise effects ofB. longumon IBS via regulation of Paneth cell function. We confirmed the beneficial effects ofB. longumon defecation habits and visceral hypersensitivity in WAS rats. Further analysis revealed thatB. longumenhanced mucosal repair, promoted lysozyme production, and ameliorated dysbiosis of the microbiota in WAS rats. These processes are closely correlated with Paneth cell functions.In vitro, we incubated primary cultured enteroids withB. longumand found thatB. longumpromoted the proliferation of these organoids; this may be attributed to the upregulation of the stem niche factors WNT3A and TGF-beta, which are secreted by Paneth cells. Based on our findings, we propose thatB. longumrelieves IBS by restoring the antimicrobial activity and stem niche maintenance function of Paneth cells.
Efficacy of Probiotic Compounds in Relieving Constipation and Their Colonization in Gut Microbiota

Yuan He,Leilei Zhu,Jialun Chen,Xin Tang,Mingluo Pan,Weiwei Yuan,Hongchao Wang

DOI: https://doi.org/10.3390/molecules27030666

IF: 4.6

2022-01-20

Molecules

Abstract:A number of studies have confirmed the relationship between constipation and gut microbiota. Additionally, many human and animal experiments have identified probiotics as effectors for the relief of constipation symptoms. In this study, probiotic compounds, including Lactobacillus acidophilus LA11-Onlly, Lacticaseibacillus rhamnosus LR22, Limosilactobacillus reuteri LE16, Lactiplantibacillus plantarum LP-Onlly, and Bifidobacterium animalis subsp. lactis BI516, were administered to mice with loperamide-induced constipation, and the impacts of these strains on constipation-related indicators and gut microbiota were evaluated. The effects of probiotic compounds on constipation relief were associated with various aspects, including gastrointestinal transit rate, number and weight of stools, serum and intestinal gastrointestinal regulatory hormones, and serum cytokines. Some of the probiotic compounds, including Limosilactobacillus reuteri, Lactiplantibacillus plantarum, and Lacticaseibacillus rhamnosus, were found to colonize the intestinal tract. Furthermore, higher dosages promoted the colonization of specific strains. This study yields a new perspective for the clinical use of probiotics to improve constipation symptoms by combining strains with different mechanisms for the alleviation of constipation.

chemistry, multidisciplinary,biochemistry & molecular biology
Bifidobacterium longum alleviates irritable bowel syndrome-related visceral hypersensitivity and microbiota dysbiosis via Paneth cell regulation.

Chunhua Zhou,Xue Fang,Jiajia Xu,Jun Gao,Ling Zhang,Jiulong Zhao,Yuting Meng,Wei Zhou,Xu Han,Yu Bai,Zhaoshen Li,Duowu Zou

DOI: https://doi.org/10.1080/19490976.2020.1782156

IF: 12.2

2020-01-01

Gut Microbes

Abstract:Although the oral administration ofBifidobacterium longum(B. longum) relieves the signs of irritable bowel syndrome (IBS) in clinical settings, the mechanisms underlying its effects are unclear. In this study, we evaluated the precise effects ofB. longumon IBS via regulation of Paneth cell function. We confirmed the beneficial effects ofB. longumon defecation habits and visceral hypersensitivity in WAS rats. Further analysis revealed thatB. longumenhanced mucosal repair, promoted lysozyme production, and ameliorated dysbiosis of the microbiota in WAS rats. These processes are closely correlated with Paneth cell functions.In vitro, we incubated primary cultured enteroids withB. longumand found thatB. longumpromoted the proliferation of these organoids; this may be attributed to the upregulation of the stem niche factors WNT3A and TGF-beta, which are secreted by Paneth cells. Based on our findings, we propose thatB. longumrelieves IBS by restoring the antimicrobial activity and stem niche maintenance function of Paneth cells.
Bifidobacterium bifidum CCFM1359 alleviates intestinal motility disorders through the BDNF-TrkB pathway

Linlin Wang,Liping Cao,Qiangqing Yu,Mengxia Liang,Zhichao Yang,Gang Wang,Jianxin Zhao,Wei Chen

DOI: https://doi.org/10.1039/d4fo03710c

IF: 6.3173

2024-12-18

Food & Function

Abstract:Intestinal motility disorder is characterised by abnormal intestinal motility function, often resulting in symptoms such as diarrhoea and constipation. Probiotics are increasingly recognised as an effective treatment for gastrointestinal disorders, including intestinal motility disorders. In this study, we used senna extract to induce an animal model of intestinal dysfunction characterised by BDNF downregulation. By assessing relevant indicators of intestinal dyskinesia, we found that Bifidobacterium bifidum CCFM1359 effectively alleviated the dyskinesia. However, this alleviating effect was nullified when a TrkB receptor inhibitor was introduced, suggesting that Bifidobacterium bifidum CCFM1359 operates through the BDNF-TrkB pathway. Further analysis revealed that Bifidobacterium bifidum CCFM1359 likely exerts its beneficial effects by regulating intestinal microecology (increasing the relative abundance of Bifidobacterium bifidum and valeric acid content while decreasing Faecalibacterium and butyric acid content), reducing intestinal inflammation (upregulating the anti-inflammatory factor IL-10 and downregulating pro-inflammatory factors TNF-α and IL-1β ), and remodelling intestinal nerves (upregulating S100β and the excitatory neurotransmitter ACh, while downregulating the inhibitory neurotransmitter nNOS). This study provides a theoretical basis for using probiotics to alleviate intestinal motility disorders.

biochemistry & molecular biology,food science & technology
Wheat Peptides Alleviate Constipation by Promoting Enteric Neurogenesis Via Machr-Mediated Calcium Signaling Pathways in Mice

Qianqian Wang,Fei Shen,Guanghua He,Juan Du,Haiying Cai,Minjie Zhao,Jing Wang,Haobin Zhao,Lida Wang,Fengqin Feng

DOI: https://doi.org/10.21203/rs.3.rs-4767421/v1

2024-01-01

Abstract:Constipation is a prevalent gastrointestinal issue. Wheat peptides (WP) effectively alleviate loperamide-induced constipation in mice. Oral administration of WP (0.5 mg/g.bw) improved defecation, small intestinal propulsion, and intestinal barrier function in mice. WP also modulated gut inflammation and enteric nervous system factors. Additionally, WP intervention effectively rectified gut microbiota dysbiosis by restoring microbial diversity and modulating gut bacteria to approach normal levels. Of particular significance, transcriptome data indicated alterations in gene expressions related to the calcium signaling pathway in the colon of constipated mice. RT-qPCR analysis further corroborated that WP upregulated the gene expression of cholinergic receptor (Chrm1), Itpr2/3, Calml3, and Calm4. Furthermore, 3D microscopy revealed that WP increased the number of enteric nerves in the colon of constipated mice. These findings suggest WP mitigate constipation by activating muscarinic acetylcholine receptors, enhancing calcium signaling, and promoting enteric neurogenesis to improve intestinal peristalsis. Overall, WP demonstrate therapeutic potential for treating constipation.
BIFIDOBACTERIUM LONGUM RELIEVES VISCERAL HYPERSENSITIVITY AND MICROBIOTA DYSBIOSIS BY REGULATING PANETH CELLS FUNCTIONS

Xue Fang,Chunhua Zhou,Jiajia Xu,Jun Gao,Duowu Zou,ZhaoShen Li

DOI: https://doi.org/10.1016/S0016-5085(20)33578-2

IF: 29.4

2020-01-01

Gastroenterology

Abstract:Background: Oral administration of Bifidobacterium longum (B.longum) can relieve symptoms of irritable bowel syndrome (IBS) in clinic.However, the detailed mechanism is still largely unknown.Methods: The water avoidance stress (WAS) IBS model was established using rats and oral administration of B. longum daily was conducted subsequently for 10 days.Then the luminal contents of the terminal ileum were collected, and microbiota were analyzed using 16S-rRNA-Sequencing.The intestinal permeability was assessed by 4000 Da fluorescent dextran-FITC (DX-4000-FITC).Further, we examined the intestinal architecture by H&E staining and immunofluorescence staining.The B. longum-enteroid co-culture system was used to investigate the effects of B. longum on Paneth cells, and the changes of Ileum epithelium and enteroids were analyzed by H&E, transmission electron microscopy, immunofluorescence staining, RNA-sequencing, QPCR and western blotting.Results: First, we confirmed that B. longum ameliorated microbiota dysbiosis and visceral hypersensitivity in WAS rats.Besides, the mucosal repair was enhanced by restoring the intestinal epithelial cells (IECs) proliferation.Second, it was found that B. longum reversed the expression of lysozyme which was downregulated in WAS.Finally, we found that B. longum neither destroyed organoid integrity nor induced cell apoptosis, but promoted the proliferation of organoids by activating the WNT and EGF signaling pathways.This effect of B. longum may be achieved by up-regulating the expression of Wnt3A, TGF-b and lysozymede which were all secreted by Paneth cells.Conclusions: We propose that B. longum restores the antimicrobial activity and stem niche maintenance functions of Paneth cells, thus relieves IBS.
A key genetic factor governing arabinan utilization in the gut microbiome alleviates constipation

Chengcheng Zhang,Leilei Yu,Chenchen Ma,Shuaiming Jiang,Yufeng Zhang,Shunhe Wang,Fengwei Tian,Yuzheng Xue,Jianxin Zhao,Hao Zhang,Liming Liu,Wei Chen,Shi Huang,Jiachao Zhang,Qixiao Zhai

DOI: https://doi.org/10.1016/j.chom.2023.10.011

IF: 31.316

2023-12-14

Cell Host & Microbe

Abstract:Zhang et al. show that B. longum strains possessing the abfA cluster can ameliorate functional constipation (FC) through enhanced arabinan utilization in the gut. Administration of abfA cluster-carrying B. longum-enriched arabinan utilization residents and beneficial metabolites that alleviate FC in both mice and humans suggests therapeutic targets for FC.

microbiology,virology,parasitology
Effect of Bifidobacterium Animalis Subsp. Lactis MN-Gup on Constipation and the Composition of Gut Microbiota.

R. Wang,J. Sun,G. Li,M. Zhang,T. Niu,X. Kang,H. Zhao,J. Chen,E. Sun,Y. Li

DOI: https://doi.org/10.3920/bm2020.0023

2020-01-01

Beneficial Microbes

Abstract:Probiotics have been reported to be associated with the alleviation of constipation. The aim of this study was to detect and determine the effect of Bifidobacterium animalis subsp. lactis MN-Gup (MN-Gup) on the alleviation of constipation in BALB/c mice and humans, and to elucidate the mechanisms underlying its effect by measuring changes in the concentration of short-chain fatty acids and the composition of microbes in human faeces. BALB/c mice were given MN-Gup by gavage for 14 days. On the 8th day of this treatment, constipation was induced by the application of diphenoxylate via gavage. The results showed that MN-Gup significantly decreased the first black stool defecation time, and significantly increased black faecal wet weight, black faecal number and the gastric-intestinal transit rate (P<0.05), thereby relieving constipation. In humans, a randomised, double-blind, placebo-controlled trial was performed to investigate the effect of MN-Gup in adults with functional constipation. After 4 weeks of intervention with placebo or MN-Gup yogurt, constipation-related symptoms (including defecation frequency, stool consistency, straining and incomplete feeling during defecation) in the constipated subjects were significantly improved in the two groups, but not different between the groups at the end of the intervention. The concentration of acetate increased significantly in the MN-Gup group compared to the placebo group and before ingestion. Significant changes in the composition of gut microbiota were found after intake of MN-Gup yogurt when compared to placebo. The relative abundances of acetate-producing Bifidobacterium, Ruminoccaceae_UCG-002 and Ruminoccaceae_UCG-005 were significantly increased after intake of MN-Gup yogurt. These results showed that MN-Gup could relieve constipation related to increased acetate-producing Bifidobacterium, Ruminoccaceae_UCG-002 and Ruminoccaceae_UCG-005.
The Different Ways Multi-Strain Probiotics with Different Ratios of Bifidobacterium and Lactobacillus Relieve Constipation Induced by Loperamide in Mice

Chenyue Zhang,Linlin Wang,Xiaoming Liu,Gang Wang,Xinmei Guo,Xuecong Liu,Jianxin Zhao,Wei Chen

DOI: https://doi.org/10.3390/nu15194230

IF: 5.9

2023-09-30

Nutrients

Abstract:Constipation is currently one of the most common gastrointestinal disorders, and its causes are diverse. Multi-strain probiotics are often considered a more effective treatment than single-strain probiotics. In this study, a constipation model was constructed using loperamide hydrochloride to evaluate the ability of a multi-strain probiotic combination of four different ratios of Bifidobacterium and Lactobacillus to regulate intestinal flora, relieve constipation, and explore the initial mechanism in mice. After four weeks of probiotic intervention, BM1, BM2, and PB2 effectively relieved constipation; however, the pathways involved were different. The Bifidobacteria-dominated formulations BM1 and BM2 mainly changed the composition and structure of the intestinal flora and significantly decreased the relative abundance of Tyzzerella, Enterorhabdus, Faecalibaculum, Gordonibacter, and Mucispirillum in stool; increased the relative abundance of Parabacteroides and the content of short-chain fatty acids (SCFAs) in stool; restored motilin (MTL) and vasoactive intestinal peptide (VIP) levels; and downregulated interleukin 6 (IL-6) and IL-8 levels in serum. This repaired the inflammatory response caused by constipation. Finally, it promoted peristalsis of the gastrointestinal tract, increasing stool water content, and relieving constipation. While Lactobacillus-dominated formula PB2 mainly restored the levels of serum neurotransmitters (MTL, SP (substance P), VIP and PYY (Peptide YY)) and inflammatory factors (IL-1, IL-6 and IL-8), it significantly decreased the relative abundance of Tyzzerella, Enterorhabdus, Faecalibaculum, Gordonibacter and Mucispirillum in stool; it then increased acetic acid content, thereby reducing the level of inflammation and changing stool properties and gastrointestinal motility.

nutrition & dietetics
Bifidobacterium bifidum Ameliorates DSS-Induced Colitis in Mice by Regulating Microbial Metabolome and Targeting Gut Microbiota

Mengzhen Han,Jingjing Liang,Mengxin Hou,Yuanye Liu,Hongcai Li,Zhenpeng Gao

DOI: https://doi.org/10.1021/acs.jafc.4c00365

2024-06-05

Abstract:Inflammatory bowel disease (IBD) is a recurrent inflammatory condition affecting the gastrointestinal tract, and its clinical treatment remains suboptimal. Probiotics have shown effectiveness in alleviating dextran sulfate sodium salt (DSS)-induced colitis, exhibiting strain-specific anti-inflammatory properties. In this study, we compared the therapeutic effects of five strains of Bifidobacterium bifidum isolated from healthy adult feces on DSS-induced colitis in mice. Additionally, we investigated the underlying mechanisms by examining gut microbiota composition and microbial metabolome. Our findings highlighted the superior efficacy of B. bifidum M1-3 compared to other strains. It significantly improved colitis symptoms, mitigated gut barrier disruption, and reduced colonic inflammation in DSS-treated mice. Moreover, gut microbiota composition analysis revealed that B. bifidum M1-3 treatment increased the abundance and diversity of gut microbiota. Specifically, it significantly increased the abundance of Muribaculaceae, Lactobacillus, Bacteroides, and Enterorhabdus, while decreasing the abundance of Escherichia-Shigella. Furthermore, our nontargeted metabolomics analysis illustrated that B. bifidum M1-3 treatment had a regulatory effect on various metabolic pathways, including tyrosine metabolism, lysine degradation, and tryptophan metabolism. Importantly, we confirmed that the therapeutic efficiency of B. bifidum M1-3 was dependent on the gut microbiota. These results are conducive to the development of probiotic products for alleviating colitis.
Bifidobacterium bifidum relieved DSS-induced colitis in mice potentially by activating the aryl hydrocarbon receptor

Qing-Yu Cui,Xiao-Ying Tian,Xi Liang,Zhe Zhang,Rui Wang,Yu Zhou,Hua-Xi Yi,Pi-Min Gong,Kai Lin,Tong-Jie Liu,Lan-Wei Zhang,Qing-yu Cui,Xiao-ying Tian,Hua-xi Yi,Pi-min Gong,Tong-jie Liu,Lan-wei Zhang

DOI: https://doi.org/10.1039/d1fo04219j

2022-01-01

Abstract:Two Bifidobacterium bifidum strains could exert their anti-inflammatory and intestinal barrier protecting effects both in vitro and in vivo , upregulate the expression of the aryl hydrocarbon receptor (AhR) in mice with DSS-induced colitis.

biochemistry & molecular biology,food science & technology
Bifidobacterium Breve Protects the Intestinal Epithelium and Mitigates Inflammation in Colitis Via Regulating the Gut Microbiota-Cholic Acid Pathway

Yaqian Li,Hongtao Xu,Liuyang Zhou,Yuwei Zhang,Wenqing Yu,Shubo Li,Jie Gao

DOI: https://doi.org/10.1021/acs.jafc.3c08527

IF: 6.1

2024-01-01

Journal of Agricultural and Food Chemistry

Abstract:In this study, we aimed to explore the protective effects of Bifidobacterium in colitis mice and the potential mechanisms. Results showed that Bifidobacterium breve (B. breve) effectively colonized the intestinal tract and alleviated colitis symptoms by reducing the disease activity index. Moreover, B. breve mitigated intestinal epithelial cell damage, inhibited the pro-inflammatory factors, and upregulated tight junction (TJ)-proteins. Gut microbiota and metabolome analysis found that B. breve boosted bile acid-regulating genera (such as Bifidobacterium and Clostridium sensu stricto 1), which promoted bile acid deconjugation in the intestine. Notably, cholic acid (CA) was closely associated with the expression levels of inflammatory factors and TJ-proteins (p < 0.05). Our in vitro cell experiments further confirmed that CA (20.24 ± 4.53 pg/mL) contributed to the inhibition of lipopolysaccharide-induced tumor necrosis factor-α expression (49.32 ± 5.27 pg/mL) and enhanced the expression of TJ-proteins (Occludin and Claudin-1) and MUC2. This study suggested that B. breve could be a probiotic candidate for use in infant foods.

Bifidobacterium longum relieves constipation by regulating the intestinal barrier of mice

Screening of Novel Probiotics with Intestinal Peristalsis-Promoting Potential Based on in Vitro and in Vivo Investigations

Bifidobacterium longum subsp. longum relieves loperamide hydrochloride-induced constipation in mice by enhancing bile acid dissociation

Bifidobacterium longum S3 alleviates loperamide-induced constipation by modulating intestinal acetic acid and stearic acid levels in mice

Different Bifidobacterium bifidum strains change the intestinal flora composition of mice via different mechanisms to alleviate loperamide-induced constipation

Bifidobacterium bifidum CCFM1163 Alleviated Cathartic Colon by Regulating the Intestinal Barrier and Restoring Enteric Nerves

Bifidobacterium animalis F1-7 in combination with konjac glucomannan improves constipation in mice via humoral transport

Lactobacillus paracasei Relieves Constipation by Acting on the Acetic Acid-5-HT-Intestinal Motility Pathway

A randomised, double-blind, placebo-controlled trial of Bifidobacterium bifidum CCFM16 for manipulation of the gut microbiota and relief from chronic constipation

<i>Bifidobacterium longum</i>alleviates irritable bowel syndrome-related visceral hypersensitivity and microbiota dysbiosis via Paneth cell regulation

Efficacy of Probiotic Compounds in Relieving Constipation and Their Colonization in Gut Microbiota

Bifidobacterium longum alleviates irritable bowel syndrome-related visceral hypersensitivity and microbiota dysbiosis via Paneth cell regulation.

Bifidobacterium bifidum CCFM1359 alleviates intestinal motility disorders through the BDNF-TrkB pathway

Wheat Peptides Alleviate Constipation by Promoting Enteric Neurogenesis Via Machr-Mediated Calcium Signaling Pathways in Mice

BIFIDOBACTERIUM LONGUM RELIEVES VISCERAL HYPERSENSITIVITY AND MICROBIOTA DYSBIOSIS BY REGULATING PANETH CELLS FUNCTIONS

A key genetic factor governing arabinan utilization in the gut microbiome alleviates constipation

Effect of Bifidobacterium Animalis Subsp. Lactis MN-Gup on Constipation and the Composition of Gut Microbiota.

The Different Ways Multi-Strain Probiotics with Different Ratios of Bifidobacterium and Lactobacillus Relieve Constipation Induced by Loperamide in Mice

Bifidobacterium bifidum Ameliorates DSS-Induced Colitis in Mice by Regulating Microbial Metabolome and Targeting Gut Microbiota

Bifidobacterium bifidum relieved DSS-induced colitis in mice potentially by activating the aryl hydrocarbon receptor

Bifidobacterium Breve Protects the Intestinal Epithelium and Mitigates Inflammation in Colitis Via Regulating the Gut Microbiota-Cholic Acid Pathway